Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To determine the benefits and harms of dose reduction or discontinuation of biological or targeted synthetic disease-modifying anti-rheumatic drugs in adults with axial spondyloarthritis and low disease activity or remission.